Latest News
NASA awards Redwire USD4m to advance drug development in microgravity
11 March 2026 - Space and defence tech company Redwire Corporation (NYSE:RDW) announced on Wednesday that NASA has granted an additional USD4m to support drug development studies aboard the International Space Station using Redwire's Pharmaceuti...
AnaCardio secures US patent for AC01, extending protection until 2042
11 March 2026 - KDventures AB (STO:KDV), a Nordic investment company focused on life sciences, announced on Wednesday that its portfolio company AnaCardio AB has received US patent approval for AC01, its drug candidate for heart failure with reduced ...
Elicera Therapeutics receives Japanese patent allowance for ELC-401 CAR T-cell candidate
11 March 2026 - Swedish clinical stage cell and gene therapy company Elicera Therapeutics AB (STO:ELIC) announced on Wednesday that the Japan Patent Office has issued a Notice of Allowance for its patent application covering the CAR T-cell candidate ...
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
11 March 2026 - Vulcan Two Group plc (LSE: VUL) has signed a five-year licence agreement with a global provider of cloud-based enterprise software to implement a central enterprise resource planning (ERP) system as part of its strategy to build a lea...
ECO Animal Health announces receipt of favourable USDA safety assessment for ECOVAXXIN MG poultry vaccine
11 March 2026 - ECO Animal Health Group plc announced on Wednesday that the United States Department of Agriculture has delivered a favourable safety assessment for its live poultry vaccine ECOVAXXIN MG, marking a key step toward marketing authorisat...